
Barclays
BCLYF | OTC
$6.33
+$0.29 (+4.89%)
Sep 24, 2026, 11:38 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.34B | 8.16B | 6.95B | 7.17B | 18.43B | 7.71B | 19.28B | 6.55B | 18.84B | 6.95B | 18.66B | 6.26B | 15.59B | 7.24B | 12.02B | 5.95B | 9.08B | 6.5B | -2.9B | 5.47B | 6.79B | 5.9B |
Cost of Revenue | n/a | n/a | 535M | n/a | n/a | n/a | 25.39B | n/a | n/a | n/a | 22.37B | n/a | n/a | n/a | 8.52B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 8.34B | 8.16B | 6.42B | 7.17B | 18.43B | 7.71B | -6.11B | 6.55B | 18.84B | 6.95B | -3.71B | 6.26B | 15.59B | 7.24B | 3.5B | 5.95B | 9.08B | 6.5B | -2.9B | 5.47B | 6.79B | 5.9B |
Operating Income | 3.25B | 2.81B | 1.86B | 2.67B | 2.48B | 2.72B | 1.66B | 2.23B | 1.94B | 2.28B | 110M | 1.89B | 1.96B | 2.6B | 1.31B | 1.97B | 1.5B | 2.23B | 1.47B | 1.96B | 2.58B | 2.4B |
Interest Income | 13.71B | 3.74B | 14.18B | 3.75B | 14.75B | 3.52B | 16.38B | 3.31B | 15.57B | 3.07B | 16.2B | 3.25B | 12.58B | 3.05B | 8.89B | 3.07B | 4.79B | 2.34B | n/a | 1.94B | 3.43B | 1.85B |
Pretax Income | 3.25B | 2.81B | 1.86B | 2.08B | 2.48B | 2.72B | 1.66B | 2.23B | 1.94B | 2.28B | 110M | 1.89B | 1.96B | 2.6B | 1.31B | 1.97B | 1.5B | 2.23B | 1.47B | 1.96B | 2.58B | 2.4B |
Net Income | 2.5B | 2.18B | 1.45B | 1.71B | 1.91B | 2.1B | 1.19B | 1.82B | 1.49B | 1.81B | 108M | 1.53B | 1.59B | 2.03B | 1.32B | 1.72B | 1.27B | 1.62B | 1.34B | 1.64B | 2.3B | 1.9B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a | 2.77B | n/a | n/a | n/a | 2.6B | n/a | n/a | n/a | 2.27B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 5.09B | 5.35B | 4.56B | 4.5B | 15.95B | 4.99B | -10.54B | 4.32B | 16.9B | 4.68B | -6.42B | 4.37B | 13.63B | 4.64B | -85M | 3.98B | 7.58B | 4.26B | -4.37B | 3.5B | 4.21B | 3.5B |
Operating Expenses | 5.09B | 5.35B | 4.56B | 4.5B | 15.95B | 4.99B | -7.77B | 4.32B | 16.9B | 4.68B | -3.82B | 4.37B | 13.63B | 4.64B | 2.19B | 3.98B | 7.58B | 4.26B | -4.37B | 3.5B | 4.21B | 3.5B |
Interest Expense | n/a | n/a | 21.69B | n/a | n/a | n/a | 25.39B | n/a | n/a | n/a | 22.37B | n/a | n/a | n/a | 8.52B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 649M | n/a | n/a | n/a | 585M | n/a | n/a | n/a | 500M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.09B | 5.35B | 5.09B | 4.5B | 15.95B | 4.99B | 17.62B | 4.32B | 16.9B | 4.68B | 18.55B | 4.37B | 13.63B | 4.64B | 10.71B | 3.98B | 7.58B | 4.26B | -4.37B | 3.5B | 4.21B | 3.5B |
Income Tax Expense | 731M | 638M | 388M | 365M | 552M | 621M | 448M | 412M | 427M | 465M | -23M | 343M | 353M | 561M | -33M | 249M | 209M | 614M | 112M | 317M | 263M | 496M |
Shares Outstanding (Basic) | 13.73B | 13.73B | 13.88B | 14.05B | 14.21B | 14.31B | 14.76B | 14.65B | 14.92B | 14.98B | 15.45B | 15.41B | 15.52B | 15.77B | 16.33B | 16.14B | 16.68B | 16.68B | 16.75B | 17.06B | 16.99B | 17.26B |
Shares Outstanding (Diluted) | 13.73B | 13.73B | 13.88B | 14.05B | 14.21B | 14.31B | 15.27B | 14.65B | 15.85B | 14.98B | 15.9B | 15.41B | 15.56B | 15.77B | 16.87B | 16.14B | 16.68B | 16.68B | 17.06B | 17.06B | 17.21B | 17.29B |
EPS (Basic) | 0.16 | 0.14 | 0.09 | 0.10 | 0.12 | 0.13 | 0.15 | 0.11 | 0.08 | 0.10 | 0.08 | 0.08 | n/a | 0.11 | 0.13 | 0.09 | n/a | 0.08 | n/a | 0.09 | n/a | 0.10 |
EPS (Diluted) | 0.16 | 0.14 | 0.09 | 0.10 | 0.12 | 0.13 | 0.14 | 0.11 | 0.08 | 0.10 | 0.08 | 0.08 | n/a | 0.11 | 0.12 | 0.09 | n/a | 0.08 | n/a | 0.09 | n/a | 0.10 |
EBITDA | 3.25B | 2.81B | 3.62B | 2.67B | 2.48B | 2.72B | 3.36B | 2.23B | 1.94B | 2.28B | 1.89B | 1.89B | 1.96B | 2.6B | 3.03B | 1.97B | 1.5B | 2.23B | 1.47B | 1.96B | 2.58B | 2.4B |
EBIT | 3.25B | 2.81B | 1.86B | 2.67B | 2.48B | 2.72B | 1.66B | 2.23B | 1.94B | 2.28B | 110M | 1.89B | 1.96B | 2.6B | 1.31B | 1.97B | 1.5B | 2.23B | 1.47B | 1.96B | 2.58B | 2.4B |
Depreciation & Amortization | n/a | n/a | 1.76B | n/a | n/a | n/a | 1.7B | n/a | n/a | n/a | 1.78B | n/a | n/a | n/a | 1.72B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BCLYF